Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Age-Period-Cohort Analysis of Creutzfeldt-Jakob Disease in Israel (1985-2019).

Created on 06 Sep 2026

Authors

Yacov Balash, Esther Kahana, Ronit Gilad, Anda Eilam, Amos D Korczyn

Published in

The Israel Medical Association journal : IMAJ. Volume 28. Issue 9. Pages 572-577.

Abstract

Although the epidemiology of Creutzfeldt-Jakob disease (CJD) in Israel has been studied extensively, it is unknown whether its incidence is mainly a result of vertical transmission due to the high penetrance of the E200K mutation in patients with familial CJD (f-CJD) compared to sporadic CJD (s-CJD), or whether there are other yet undiscovered contributing factors.
To conduct an age-period-cohort (APC) analysis of Creutzfeldt-Jakob disease in Israel.
In this APC analysis, we used a web-based statistical tool to identify whether patient age, period of birth, and cohort had any effect on incidence trends of s-CJD and f-CJD.
APC analysis demonstrated no significant shifts in net drift, indicating the absence of any overall trend of changes over time. Cohort analysis revealed that individuals affected by either s-CJD or f-CJD who were mostly born in Israel in the second half of the 20th century exhibited the same risk as those born mainly in Libya at the beginning of 20th century. There were no changes in risk of s-CJD and f-CJD between 1985 and 2019.
The incidence rates of s-CJD and f-CJD in Israel have remained unchanged, indicating that the probability of a future increase in the incidence is negligible.

PMID:
42701842
Bibliographic data and abstract were imported from PubMed on 06 Sep 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement